全文获取类型
收费全文 | 2005篇 |
免费 | 52篇 |
国内免费 | 96篇 |
出版年
2023年 | 16篇 |
2022年 | 38篇 |
2021年 | 35篇 |
2020年 | 35篇 |
2019年 | 33篇 |
2018年 | 37篇 |
2017年 | 56篇 |
2016年 | 41篇 |
2015年 | 56篇 |
2014年 | 147篇 |
2013年 | 145篇 |
2012年 | 128篇 |
2011年 | 144篇 |
2010年 | 114篇 |
2009年 | 79篇 |
2008年 | 101篇 |
2007年 | 110篇 |
2006年 | 84篇 |
2005年 | 79篇 |
2004年 | 72篇 |
2003年 | 79篇 |
2002年 | 63篇 |
2001年 | 42篇 |
2000年 | 44篇 |
1999年 | 49篇 |
1998年 | 53篇 |
1997年 | 32篇 |
1996年 | 23篇 |
1995年 | 32篇 |
1994年 | 22篇 |
1993年 | 17篇 |
1992年 | 16篇 |
1991年 | 16篇 |
1990年 | 15篇 |
1989年 | 16篇 |
1988年 | 10篇 |
1987年 | 10篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1973年 | 1篇 |
1971年 | 2篇 |
1970年 | 3篇 |
排序方式: 共有2153条查询结果,搜索用时 16 毫秒
141.
Monitoring and management strategy for Helicoverpa armigera resistance to Bt cotton in China 总被引:6,自引:0,他引:6
Wu K 《Journal of invertebrate pathology》2007,95(3):220-223
The cotton bollworm, Helicoverpa armigera, is one of the most important insect pests in cotton growing regions of China. Transgenic cotton that expresses a gene derived from the bacterium Bacillus thuringiensis (Bt) has been deployed for combating cotton bollworm since 1997. Natural refugees derived from the mixed planting system consisting of cotton, corn, soybean, vegetables, peanut and others on single-family farms of a small scale were used for delaying the evolution of resistance to Bt cotton. Susceptibility of H. armigera field populations to the Bt insecticidal protein Cry1Ac was monitored from 1997 to 2006. The results indicate that the field populations are still susceptible to Cry1Ac, and monitoring indication no apparent shifts in susceptibility in field populations of this important pest. 相似文献
142.
Shibayama Y Kawachi A Onimaru S Tokunaga J Ikeda R Nishida K Kuchiiwa S Nakagawa S Takamura N Motoya T Takeda Y Yamada K 《Life sciences》2007,81(2):103-108
An herbal health care supplement, St John's Wort (SJW, Hypericum perforatum) has become widely used in the treatment of depression, and is known to interact with therapeutic drugs. Here we report a preventive effect of SJW on cisplatin nephrotoxicity in rats. Rats were given SJW (400 mg/kg/day, p.o.) for 10 consecutive days, and were injected with cisplatin (5 mg/kg, i.v.) on the day after the final SJW treatment. Cisplatin treatment increased the serum creatinine level, which is an index of nephrotoxicity, to 1.51+/-0.22 mg/dl (mean+/-SE) from 0.28+/-0.05 mg/dl (control) on day 5 after the cisplatin injection. This increase fell significantly to 0.86+/-0.13 mg/dl by pre-treatment with SJW. Cisplatin-induced histological abnormality of the kidney was blocked by pre-treatment with SJW. When SJW was administered for 10 days, the amounts of renal metallothionein (MT) and hepatic multidrug resistance protein 2 (Mrp2) were increased to 164.8+/-13.0% and 220.8+/-39.3% (mean+/-SE) of controls, respectively. GSH levels in the kidney and liver were not changed. Total and free cisplatin concentration in serum was not influenced by SJW treatment. In conclusion, the results suggest that pre-treatment with SJW may diminish cisplatin nephrotoxicity. 相似文献
143.
Current HIV therapy, although highly effective, may cause very serious side effects, making adherence to the prescribed regimen
difficult. Mathematical modeling may be used to evaluate alternative treatment regimens by weighing the positive results of
treatment, such as higher levels of helper T cells, against the negative consequences, such as side effects and the possibility
of resistance mutations. Although estimating the weights assigned to these factors is difficult, current clinical practice
offers insight by defining situations in which therapy is considered “worthwhile”. We therefore use clinical practice, along
with the probability that a drug-resistant mutation is present at the start of therapy, to suggest methods of rationally estimating
these weights. In our underlying model, we use ordinary differential equations to describe the time course of in-host HIV
infection, and include populations of both activated CD4+ T cells and CD8+ T cells. We then determine the best possible treatment regimen, assuming that the effectiveness of the drug can be continually
adjusted, and the best practical treatment regimen, evaluating all patterns of a block of days “on” therapy followed by a
block of days “off” therapy. We find that when the tolerance for drug-resistant mutations is low, high drug concentrations
which maintain low infected cell populations are optimal. In contrast, if the tolerance for drug-resistant mutations is fairly
high, the optimal treatment involves periods of reduced drug exposure which consequently boost the immune response through
increased antigen exposure. We elucidate the dependence of the optimal treatment regimen on the pharmacokinetic parameters
of specific antiviral agents. 相似文献
144.
The outer membrane proteins TolC and EefC from Enterobacter aerogenes are involved in multidrug resistance as part of two resistance-nodulation-division efflux systems. To gain more understanding in the molecular mechanism underlying drug efflux, we have undertaken an electrophysiological characterization of the channel properties of these two proteins. TolC and EefC were purified in their native trimeric form and then reconstituted in proteoliposomes for patch-clamp experiments and in planar lipid bilayers. Both proteins generated a small single channel conductance of about 80 pS in 0.5 M KCl, indicating a common gated structure. The resultant pores were stable, and no voltage-dependent openings or closures were observed. EefC has a low ionic selectivity (PK/PCl = ∼ 3), whereas TolC is more selective to cations (PK/PCl = ∼ 30). This may provide a possible explanation for the difference in drug selectivity between the AcrAB-TolC and EefABC efflux systems observed in vivo. The pore-forming activity of both TolC and EefC was severely inhibited by divalent cations entering from the extracellular side. Another characteristic of the TolC and EefC channels was the systematic closure induced by acidic pH. These results are discussed in respect to the physiological functions and structural models of TolC and EefC. 相似文献
145.
目的了解临床分离铜绿假单胞菌对喹诺酮类等抗菌药物的耐药性。方法琼脂稀释法测定86株铜绿假单胞菌对5种氟喹诺酮类抗菌药物以及头孢吡肟、美罗培南的耐药性。结果铜绿假单胞菌对诺氟沙星、氧氟沙星、左氧氟沙星、环丙沙星、加替沙星的耐药率分别为50%、61.6%、51.2%、48.8%、51.2%;对头孢吡肟和美罗培南的耐药率分别为30.2%、23.2%。结论铜绿假单胞菌对氟喹诺酮类抗菌药物耐药显著,临床应加强检测和监测。 相似文献
146.
Markussen MD Heiberg AC Fredholm M Kristensen M 《Journal of biochemical and molecular toxicology》2007,21(6):373-381
The present study characterizes the anticoagulant resistance mechanism in a Danish bromadiolone-resistant strain of Norway rats (Rattus norvegicus), with a Y139C VKORC1 mutation. We compared liver expression of the VKORC1 gene, which encodes a protein of the vitamin K 2,3-epoxide reductase complex, the NQO1 gene, which encodes a NAD(P)H quinone dehydrogenase and the Calumenin gene between bromadiolone-resistant and anticoagulant-susceptible rats upon saline and bromadiolone administration. Additionally, we established the effect of bromadiolone on the gene expression in the resistant and susceptible phenotype. Bromadiolone had no effect on VKORC1 and NQO1 expression in resistant rats, but induced significantly Calumenin expression in the susceptible rats. Calumenin expression was similar between the resistant and the susceptible rats upon saline administration but twofold lower in resistant rats after bromadiolone treatment. These results indicate that Danish bromadiolone resistance does not involve an overexpression of calumenin. Independent of the treatment, we observed a low VKORC1 expression in resistant rats, which in conjugation with the Y139C polymorphism most likely explains the low VKOR activity and the enhanced need for vitamin K observed in Danish resistant rats. Furthermore the bromadiolone resistance was found to be associated with a low expression of the NQO1 gene. 相似文献
147.
Herr I Gassler N Friess H Büchler MW 《Apoptosis : an international journal on programmed cell death》2007,12(2):271-291
More than a quarter of a century ago, the phenomenon of glucocorticoid-induced apoptosis in the majority of hematological
cells was first recognized. More recently, glucocorticoid-induced antiapoptotic signaling associated with apoptosis resistance
has been identified in cells of epithelial origin, most of malignant solid tumors and some other tissues. Despite these huge
amount of data demonstrating differential pro- and anti-apoptotic effects of glucocortioids, the underlying mechanisms of
cell type specific glucocorticoid signaling are just beginning to be described. This review summarizes our present understanding
of cell type-specific pro- and anti-apoptotic signaling induced by glucocorticoids. In the first section we give a summary
and update of known glucocorticoid-induced pathways mediating apoptosis in hematological cells. We shortly introduce mechanisms
of glucocorticoid resistance of hematological cells. We highlight and discuss the emerging molecular evidence of a general
induction of survival signaling in epithelial cells and carcinoma cells by glucocorticoids. We provide a model for glucocorticoid-induced
resistance in cells growing in a tissue formation. Thus, attachment to the extracellular matrix and cell-cell contacts typical
for e.g. epithelial and tumor cells may be crucially involved in switching the balance of several interacting pathways to
survival upon treatment with glucocorticoids. 相似文献
148.
This study evaluated the effect of a signal on resistance to change using a multiple schedule of reinforcement. Experiment 1 presented pigeons with three schedules: a signaled delay to reinforcement schedule (a two-link chain schedule with a variable-interval 120-s initial link followed by a 5-s fixed-time schedule), an unsignaled delay schedule (a comparable two-link tandem schedule), and an immediate, zero-delay variable-interval 125-s schedule. Two separate disruption procedures assessed resistance to change: extinction and adding a variable-time 20-s schedule of reinforcement to the inter-component interval. Resistance to change tests were conducted twice, once with the signal stimulus (the terminal link of the chain schedule) present and once with it absent. Results from both disruption procedures showed that signal absence reduced resistance to change for the pre-signal stimulus. In probe choice tests subjects strongly preferred the signal stimulus over the unsignaled stimulus and exhibited no reliable preference when given a choice between the signal stimulus and immediate stimulus. Experiment 2 presented two equal signaled schedules where, during resistance to change tests, the signal remained for one schedule and was removed for the second. Resistance to change was consistently lower when the signal was absent. 相似文献
149.
Multidrug resistance (MDR) is the result of overexpression of membrane bound proteins that efflux chemotherapeutic drugs from the cells. Two proteins, P-glycoprotein (P-gp) and multidrug-resistance associated protein-1 (MRP-1) efflux chemotherapeutic agents out of the cancer cell that decrease intracellular drug accumulation, thereby decreasing the effectiveness of many chemotherapeutic agents. In the present study, the ethanolic extract of the roots of Stemona curtisii Hook. was tested for the potential ability to modulate the MDR phenotype and function of P-gp and MRP-1. The S. curtisii extract reversed the resistance to putative chemotherapeutic agents, including vinblastine, paclitaxel and colchicine of KB-V1 cells (MDR human cervical carcinoma with high P-gp expression) in a dose-dependent manner, but not in KB-3-1 cells (drug sensitive human cervical carcinoma, which lack P-gp expression). The root extract also increased the intracellular uptake and retention of (3)[H]-vinblastine in KB-V1 cells dose dependently. The extract did not influence MDR phenotype-mediated MRP-1 in MRP1-HEK293 (human embryonic kidney cells stably transfected with pcDNA3.1-MRP1-H10 which show high MRP-1 expression) and pcDNA3.1-HEK293 (wild type). In summary, the S. curtisii root extract modulated P-gp activity but not MRP-1 activity. The result obtained from this study strongly indicated that S. curtisii extract may play an important role as a P-gp modulator as used in vitro and may be effective in the treatment of multidrug-resistant cancers. The purified form of the active components of S. curtisii extract should be investigated in more details in order to explain the molecular mechanisms involved in P-gp modulation. This is the first report of new biological activity in this plant, which could be a potential source of a new chemosensitizer. 相似文献
150.
P-glycoprotein (P-gp)-mediated multiple drug resistance (MDR) is perhaps the most thoroughly studied cellular mechanism of cytotoxic drug resistance. Its efflux function can be circumvented by a wide range of pharmacological agents in vitro and in vivo. Most of these agents are pharmaceuticals used clinically for conditions other than cancer. However, their use in alleviating MDR is limited because the concentrations required for inhibition of the pump surpass their dose-limiting toxicity. The aim of this research is to study the role of gypenosides, isolated from Gynostemma pentaphyllum, as modulators of P-gp-mediated MDR in tumor cells, at both cellular and plasma membrane level. In the presence of total gypenoside preparation (0.1 mg/ml), an approximately 15-fold reversal of colchicine (COL) resistance was observed in P-gp-overexpressed CEM/VLB100 cells. However, the gypenoside sample showed no reversal effect in cells treated with vinblastine and taxol. A purified gypenoside sample (gypenoside fraction 100) exhibited even more significant reversal of COL resistance (42-fold) in the CEM/VLB100 cells. Further examination of the reversal effect of fraction 100 in membrane vesicles derived from CEM/VLB100 cells using the continuous fluorescence method found that gypenoside fraction 100 at 0.1 mg/ml completely abolished the transport of fluorescein–COL. 相似文献